SBIR/STTR Research Award

Novel Methods for Rapid Monitoring of Decontamination Efficacy

Award identifier 11eaf4d64c6b6448a84fe2803c0bcea14963564bdea5b9eee03315df04d1cf40Awarding agency Department of Defense · Army

Award amount

$99,998

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
ADVANCED CYTOMETRY INSTRUMENTATION SYSTEMS LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
YLGMJXLP7TW5
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Not Available "Conducting military operations in an environment containing biowarfare agents requires sophisticated and rapid laboratory tools to develop and test suitable decontaminants. Flow cytometers are useful in R&D and clinical laboratories because of theirability to obtain spectroscopic information from large numbers of individual cells or beads. A custom-built, autonomous flow cytometer is proposed to monitor the efficacy of numerous candidate liquid decontaminants against bacterial pathogens and theirtoxins. A novel robust device is proposed that will reduce the size of the optical interrogation spot to accommodate the small size of bacteria. Other proposed methods take advantage of microfluidic flow cells and sensitive detection techniques. Allequipment will utilize a sample carrousel to facilitate the automated analysis of a large number of candidate decontamination agents. Unfortunately, a single preparative assay is not universally adaptable to determining the efficacy of decontaminationprocedures for bacteria (vegetative and nonvegetative) and their toxins. ACIS proposes a unique assay for bacteria, spores and toxins. The proposed methods provide time-dependent quantitative measures of a decontamination agent's effectiveness. Theproject will conclude with a final report describing the performance of both the equipment and the assays and recommendations for future work to be considered for Phase II. In addition to military applications, the same technology will be useful incombating bioterrorism on the homefront and will be routinely used by the pharmaceutical industry (to develop antibiotics and antimicrobial agents) and by manufacturers of consumer cleaning products and be the foundation for commercial biomonitoringequipment."

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

7 SBIR/STTR records share this UEI (2001–2022). Reported award amounts total $2,748,972. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Energy, Department of Defense

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.